Private Capital Group’s ResMed RMD Stock Holding History

Private Capital Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$3K	Sell	13 -6	-32%	-$1.28K	﹤0.01%	1449
2022 Q1	$5K	Hold	19	–	–	﹤0.01%	1534
2021 Q4	$5K	Hold	19	–	–	﹤0.01%	1561
2021 Q3	$5K	Hold	19	–	–	﹤0.01%	1597
2021 Q2	$5K	Hold	19	–	–	﹤0.01%	1567
2021 Q1	$4K	Sell	19 -6	-24%	-$1.2K	﹤0.01%	1598
2020 Q4	$5K	Buy	25 +6	+32%	+$1.2K	﹤0.01%	1573
2020 Q3	$3K	Hold	19	–	–	﹤0.01%	1634
2020 Q2	$4K	Hold	19	–	–	﹤0.01%	1567
2020 Q1	$3K	Sell	19 -509	-96%	-$81.1K	﹤0.01%	1615
2019 Q4	$81K	Hold	528	–	–	0.02%	517
2019 Q3	$71K	Buy	+528	New	+$69.2K	0.01%	622
2019 Q2	–	Sell	-19	Closed	-$2K	–	2391
2019 Q1	$2K	Hold	19	–	–	﹤0.01%	1920
2018 Q4	$2K	Buy	+19	New	+$2.04K	﹤0.01%	1907
2018 Q2	–	Sell	-6	Closed	-$1K	–	2231
2018 Q1	$1K	Buy	+6	New	+$567	﹤0.01%	2007

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Private Capital Group's RMD Position: Q2 2022 in Review

Private Capital Group reduced its ResMed (RMD) stake by 32% in Q2 2022, selling an estimated $1.28K and leaving 13 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1449.

Private Capital Group first reported a position in RMD in Q1 2018 and has held it in 15 quarters since. The position peaked at $81K in Q4 2019. 677 funds tracked by Wall St. Rank hold RMD as of Q2 2022.

Private Capital Group held 13 shares of ResMed worth $3K as of Q2 2022.
Private Capital Group sold 6 ResMed shares in Q2 2022, an estimated $1.28K.
ResMed made up ﹤0.01% of Private Capital Group's portfolio in Q2 2022, its #1449 holding.
Private Capital Group first reported a position in ResMed in Q1 2018 and has held it in 15 quarters since.
Private Capital Group's ResMed position peaked at $81K in Q4 2019.
677 funds tracked by Wall St. Rank held ResMed as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.